Cholesteryl butyrate in solid lipid nanospheres as an alternative approachfor butyric acid delivery

Citation
C. Pellizzaro et al., Cholesteryl butyrate in solid lipid nanospheres as an alternative approachfor butyric acid delivery, ANTICANC R, 19(5B), 1999, pp. 3921-3925
Citations number
22
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
5B
Year of publication
1999
Pages
3921 - 3925
Database
ISI
SICI code
0250-7005(199909/10)19:5B<3921:CBISLN>2.0.ZU;2-R
Abstract
Background: Cholesteryl-butyrate chosen as lipid matrix of solid lipid nano spheres (SLNs) could be a suitable pro-drug to delivery butyric acid and ov ercome one of the most limiting disadvantages of the compound: the short ha lf-life due to a rapid metabolism. Methods: We evaluated the antiproliferat ive effect, with respect to that of sodium butyrate, of four SLNs (SLN1, SL N2, SLN3 and SLN4) characterized by a different concentration of cholestery l-butyrate (range, 1.7-30 mM) on NIH-H460, a non-small cell lung carcinoma cell line. Results: After 6 days of treatment, all SLN preparations induced a dose-dependent inhibition of NHI-H460 cel growth: the most effective SLN preparation (SLN1) was able to induce a complete growth inhibition already at 0.25 mM, a concentration at which sodium butyrate induced only a a 55% inhibition. Fluoresce microscopy showed that 6-coumarin-tagged SLNs were al most completely internalized by cel after 5 min of treatment. Conclusions: The present results indicate that owing to their peculiar characteristics, SLNs could be an interesting alternative approach for butyric acid delivery into tumor cells.